Lonza Licences AG

A) Holding and exercising the rights and obligations arising from the so-called Intercompany Licence Agreement between the Company as licensee and Lonza Group AG as licensor, whereby the Company is granted a worldwide license to certain patents, know-how and other intellectual property rights (the "Licensed Intellectual Property"), including any ancillary agreements related to the Intercompany Licence Agreement; b) Holding and exercising the rights of the Company under the Assignment Agreement between the Company and Lonza Group AG (the "Assignment Agreement"); c) Asserting and enforcing the right to receive the license pursuant to Section 2.3 of the Conditional Assignment Agreement between Lonza Group and Lonza Swiss Licences AG (the "Conditional Assignment Agreement") and holding, acquiring, using, exploiting or fulfilling the rights and obligations under such license. d) Holding and exploiting the Licensed Intellectual Property and all rights licensed under the Conditional Assignment Agreement as assigned under the Assignment Agreement; e) Holding and exercising the rights and obligations (as successor to Lonza Sales AG) under the license agreement dated December 21, 2000, including any amendments, with Human Genome Sciences, Inc. (the "Primary Licence Agreement"); f) In connection with the Company's performance under the Primary Licence Agreement: entering into, holding and exercising the rights and obligations under corresponding agreements with Lonza Group AG (including its 100% subsidiaries) and other parties; and g) In connection with the Company's rights and obligations related to the claims, assets and agreements referred to in paragraphs (a) to (e) above: entering into, holding and exercising the rights and obligations under corresponding additional agreements. The following activities are explicitly excluded from the Company's purpose: a) Any activities, business operations and the acquisition, leasing or renting of properties or other assets outside the scope of the aforementioned Company purpose; b) Borrowing from third parties, unless permitted under the purchase agreement referred to in paragraph (d); c) Guaranteeing or fulfilling any payment or other obligations of third parties or assuming any obligation to perform a service of a third party; d) Pledging or granting any security interests in any asset or all assets of the Company, except (i) the security interests permitted under the Intellectual Property Security Agreement and Pledge with HEALTHCARE ROYALTY PARTNERS II, L.P. or (ii) as permitted under the purchase agreement (as described in the Intellectual Property Security Agreement and Pledge); e) Directly or indirectly owning or committing to directly or indirectly acquire any interests in companies or entities of any kind; f) Assigning the Company's entire assets for creditor satisfaction in the context of a private composition; g) Purchasing, selling, encumbering or disposing of any assets, unless provided for in the purchase agreement referred to in paragraph (d) and the related agreements.